Cai Lei's Award and Asset Allocation in AI-Driven Rare Disease Drug R&D

I noticed an interesting detail: Cai Lei's team used AI to build a "research brain" that validated a potential path to curing ALS in animal models. This isn't just a simple scientific breakthrough; it's a classic case of "using tech leverage to pry open high-barrier markets."